Bg pattern

CEQUA 0.9 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

5.0 (100)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CEQUA 0.9 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show translation

Introducción

Prospecto: información para el paciente

Cequa 0,9 mg/ml colirio en solución en envase unidosis

ciclosporina

Lea todo el prospecto detenidamente antes de empezar a usar este medicamento, porque contiene información importante para usted.

  • Conserve este prospecto, ya que puede tener que volver a leerlo.
  • Si tiene alguna duda, consulte a su médico o farmacéutico.
  • Este medicamento se le ha recetado solamente a usted, y no debe dárselo a otras personas aunque tengan los mismos síntomas que usted, ya que puede perjudicarles.
  • Si experimenta efectos adversos, consulte a su médico o farmacéutico, incluso si se trata de efectos adversos que no aparecen en este prospecto. Ver sección 4.

Contenido del prospecto

  1. Qué es Cequa y para qué se utiliza
  2. Qué necesita saber antes de empezar a usar Cequa
  3. Cómo usar Cequa
  4. Posibles efectos adversos
  5. Conservación de Cequa
  6. Contenido del envase e información adicional

1. Qué es Cequa y para qué se utiliza

Cequa contiene el principio activo ciclosporina. La ciclosporina forma parte de un grupo de medicamentos denominados inmunodepresores, que se utilizan para reducir la inflamación.

Ciclosporina se utiliza para el tratamiento de la enfermedad de ojo seco de moderada a grave (queratoconjuntivitis seca) en pacientes adultos que no han respondido adecuadamente a las lágrimas artificiales.

Debe consultar a un médico si empeora o si no mejora.

Debe acudir a la consulta de su médico como mínimo cada 3 meses para que evalúe el efecto de este medicamento.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Qué necesita saber antes de empezar a usar Cequa

No use Cequa:

  • si es alérgico a la ciclosporina o a alguno de los demás componentes de este medicamento (incluidos en la sección 6);
  • si ha sufrido o sufre cáncer en o alrededor del ojo;
  • si sufre una infección ocular.
Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

Advertencias y precauciones

Utilice este medicamento únicamente como colirio para el (los) ojo(s).

Consulte a su médico o farmacéutico antes de empezar a usar este medicamento:

  • si ha tenido anteriormente una infección ocular por el virus del herpes que pueda haber dañado la parte frontal transparente del ojo (córnea);
  • si está tomando algún medicamento que contenga esteroides;
  • si está tomando algún medicamento parat tratar el glaucoma.

Se debe quitar las lentes de contacto antes de usar este medicamento; puede volver a ponérselas 15 minutos después de la administración de este medicamento.

Niños y adolescentes

No se debe usar este medicamento en niños y adolescentes menores de 18 años.

Otros medicamentos y Cequa

Informe a su médico o farmacéutico si está utilizando, ha utilizado recientemente o pudiera tener que utilizar cualquier otro medicamento.

Consulte a su médico si está usando un colirio que contenga esteroides, ya que estos pueden aumentar el riesgo de efectos adversos.

Se debe usar este medicamento al menos 15 minutos después de utilizar cualquier otro colirio.

Embarazo y lactancia

Si está embarazada o en periodo de lactancia, cree que podría estar embarazada o tiene intención de quedarse embarazada, consulte a su médico o farmacéutico antes de utilizar este medicamento.

No debe utilizar este medicamento si está embarazada.

Si se puede quedar embarazada, debe utilizar anticonceptivos mientras use este medicamento.

Es posible que haya cantidades muy pequeñas de ciclosporina en la lecha materna. Si está en periodo de lactancia consulte a su médico antes de utilizar este medicamento.

Conducción y uso de máquinas

Puede que tenga visión borrosa inmediatamente después de utilizar este medicamento. En este caso, espere hasta que su visión sea clara antes de conducir o utilizar máquinas.

Cequa contiene fosfatos

Este medicamento contiene 0,0159 mg de fosfatos en cada gota. Si sufre de daño grave en la capa trasparente de la parte frontal del ojo (córnea), el tratamiento con fosfatos, en casos muy raros, puede provocar parches nublados en la córnea debido al calcio.

3. Cómo usar Cequa

Siga exactamente las instrucciones de administración de este medicamento indicadas por su médico o farmacéutico. En caso de duda, consulte de nuevo a su médico o farmacéutico.

La dosis recomendada es una gota en cada ojo afectado, dos veces al día, con un intervalo aproximado de 12 horas.

Instrucciones de uso

Espacio en blanco rectangular sin elementos visiblesManos sosteniendo un dispositivo inhalador cilíndrico con un anillo alrededor del extremo centralMano inyectando medicamento en la piel con una aguja hipodérmica y un pliegue cutáneo levantadoSiga atentamente estas instrucciones y consulte a su médico o farmacéutico si hay algo que no entiende.

Manos sosteniendo y abriendo la boca de un paciente para administrar medicamento oral

1 2 3

  • Lávese las manos.
  • Si tiene puestas las lentes de contacto, quitéselas antes de usar el colirio; puede volvérselas a poner 15 minutos después de haberse administrado las gotas.
  • Abra la bolsa de aluminio, extraiga un envase unidosis, e inserte el resto de envases unidosis de nuevo en el interior de la bolsa de aluminio.
  • Gire la tapa (figura 1).
  • Baje el párpado inferior (figura 2).
  • Eche la cabeza hacia atrás y mire al techo.
  • Suavemente, apriete para echar una gota de medicamento en el ojo. Asegúrese de no tocar el ojo con la punta del envase unidosis.
  • Parpadee varias veces para distribuir la gota en el ojo.
  • Después de aplicar la gota, presione con un dedo la comisura del ojo junto a la nariz y cierre suavemente los párpados durante 2 minutos (figura 3)(esto favorece el efecto local).
  • Si utiliza el colirio en ambos ojos, repita estos pasos en el otro ojo.
  • Tire el envase unidosis en cuanto lo haya utilizado, incluso si aún queda algo de medicamento en él.
  • Debe mantener los envases unidosis restantes en la bolsa de aluminio.

Si la gota cae fuera del ojo, inténtelo de nuevo.

Si usa más Cequa del que debe, lávese el ojo con agua. No se aplique más gotas hasta que le corresponda aplicar la siguiente dosis.

En caso de sobredosis o ingestión accidental, consulte inmediatamente a su médico o farmacéutico o llame al Servicio de Información Toxicológica, teléfono 91 562 04 20 indicando el medicamento y la cantidad ingerida.

Si olvidó usar Cequa,continúe con la siguiente dosis prevista.

No se aplique una dosis doble para compensar las dosis olvidadas. No use más de una gota a la vez en el ojo(s) afectado(s).

Si interrumpe el tratamiento con Cequa, consúltelo antes con su médico.

Si tiene cualquier otra duda sobre el uso de este medicamento, pregunte a su médico o farmacéutico.

4. Posibles efectos adversos

Al igual que todos los medicamentos, este medicamento puede producir efectos adversos, aunque no todas las personas los sufran.

Se han observado los siguientes efectos adversos:

Los efectos adversos más frecuentes se producen en y alrededor de los ojos.

Muy frecuentes (pueden afectar a más de 1 de cada 10 personas): dolor o malestar cuando se aplica una gota por primera vez.

Frecuentes (pueden afectar a hasta 1 de cada 10 personas): enrojecimiento del ojo, irritación del ojo, ojos llorosos, irritación en el ojo.

Poco frecuentes (pueden afectar a hasta 1 de cada 100 personas): aumento del lagrimeo del ojo, aumento de la sensibilidad a la luz, dolor en el ojo, hinchazón de la conjuntiva (piel que recubre la parte blanca del ojo), inflamación de los márgenes del párpado, infecciones oculares y perioculares, cefalea e irritación de garganta.

Comunicación de efectos adversos

Si experimenta cualquier tipo de efecto adverso, consulte a su médico o farmacéutico, incluso si se trata de posibles efectos adversos que no aparecen en este prospecto. También puede comunicarlos directamente a través del Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano: www.notificaRAM. Mediante la comunicación de efectos adversos usted puede contribuir a proporcionar más información sobre la seguridad de este medicamento.

5. Conservación de Cequa

Mantener este medicamento fuera de la vista y del alcance de los niños.

No utilice este medicamento después de la fecha de caducidad que aparece en la caja, la bolsa de aluminio y los envases unidosis después de “CAD”. La fecha de caducidad es el último día del mes que se indica.

No conservar por encima de 25°C. No congelar. Después de abrir las bolsas de aluminio, se deben mantener los envases unidosis en ellas para evitar la evaporación.El período de validez tras la apertura de la bolsa de aluminio: 5 días. Desechar inmediatamente después de su uso cualquier envase unidosis individual abierto con restos de solución.

No utilice este medicamento si observa partículas visibles.

Los medicamentos no se deben tirar por los desagües ni a la basura. Deposite los envases y los medicamentos que no necesita en el Punto SIGRE de la farmacia. Pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que ya no necesita. De esta forma, ayudará a proteger el medio ambiente.

6. Contenido del envase e información adicional

Composición de Cequa

  • El principio activo es ciclosporina. Un mililitro de Cequa contiene 0,9 mg de ciclosporina.
  • Los demás componentes son: macrogolglicerol hidroxiestearato, octoxinol-40, dihidrógenofosfato de sodio dihidrato (E339), hidrogenofosfato de sodio anhidro (E339), cloruro sódico, povidona (E1201), ácido clorhídrico (para ajuste del pH) (E507), hidróxido sódico (para ajuste del pH) (E524) y agua para preparaciones inyectables.

Aspecto del producto y contenido del envase

Cequa es una solución clara, incolora en envases unidosis.

Se suministra en envases unidosis de polietileno de baja densidad (LDPE).

Cada envase unidosis contiene 0,25 ml de colirio en solución.

Los envases unidosis se acondicionan en una bolsa sellada de aluminio con recubrimiento de polietileno.

Tamaños de envases: envases con 60 o 180 envases unidosis, o envase múltiple conteniendo 180 unidades (3 cajas de cartón con 60 envases unidosis cada una).

Puede que solamente estén comercializados algunos tamaños de envases.

Titular de la autorización de comercialización y responsable de la fabricación

Titular de la autorización de comercialización

Sun Pharmaceutical Industries BV

Polarisavenue 87,

2132JH Hoofddorp,

Países Bajos

Responsable de la fabricación

Laboratoire Unither

1 Rue De L’Arquerie

Coutances 50200

Francia

Pueden solicitar más información respecto a este medicamento dirigiéndose al representante local del titular de la autorización de comercialización:

Sun Pharma Laboratorios, S.L.

Rambla de Catalunya 53-55

08007 Barcelona

España

Tel: +34 93 342 78 90

Este medicamento está autorizado en los estados miembros del Espacio Económico Europeo con los siguientes nombres:

Holanda: Cequa 0.9 mg/ml oogdruppels, oplossing in verpakking voor eenmalig gebruik

Austria: Cequa 0,9 mg/ml Augentropfen, Lösung im Einzeldosisbehältnis

Alemania: Cequa 0,9 mg/ml Augentropfen, Lösung im Einzeldosisbehältnis

Dinamarca: Sekua 0.9 mg/ml øjendråber, opløsning i enkeltdosisbeholder

España: Cequa 0,9 mg/ml colirio en solución en envase unidosis

Finlandia: Cequa 0.9 mg/ml silmätipat, liuos kerta- annospakkauksessa

Francia: Cequa 0,9 mg/mL, collyre en solution en récipient unidose

Italia: Cequa

Noruega: Cequa 0.9 mg/ml øyedråper, oppløsning i endosebeholder

Suecia: Cequa 0.9 mg/ml ögondroppar, lösning i endosbehållare

Fecha de la última revisión de este prospecto: Marzo 2024

La información detallada de este medicamento está disponible en la página web de la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) http://www.aemps.gob.es/

Online doctors for CEQUA 0.9 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS

Discuss questions about CEQUA 0.9 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (100)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

5.0 (203)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

0.0 (11)
Doctor

Rita Isabel Calero Garcia

General medicine 2 years exp.

Dr. Rita Isabel Calero Garcia is a physician with extensive experience in emergency medical care, general medicine, and healthcare assistance in various clinical and out-of-hospital settings.

She currently works as a physician at the Canary Islands Emergency Service (Servicio de Urgencias Canario – SUC), where she is responsible for the assessment and care of patients in medical emergency situations, performing the initial diagnosis, patient stabilization, and coordination with hospital services when necessary.

She has also developed her professional activity within the Primary Care Management Service, providing consultations in general medicine. In this setting she is responsible for patient follow-up, management of acute and chronic conditions, as well as health promotion and disease prevention.

She has also worked as a physician in a mobile ICU unit, providing medical assistance in out-of-hospital emergencies, treating critical patients and participating in medicalized patient transport.

In addition, she has collaborated with the Red Cross, participating in healthcare support units, providing medical assistance at events and supporting emergency interventions.

Furthermore, she has provided medical services in the private sector with Salvaser, conducting clinical assessments of patients and providing healthcare services within private medical services.

5.0 (101)
Doctor

Jorge Correa Bellido

General medicine 7 years exp.

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

5.0 (1235)
Doctor

Andrei Popov

General medicine 7 years exp.

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
0.0 (0)
Doctor

Chikeluo Okeke

General medicine 4 years exp.

Dr Chikeluo Okeke is an internal medicine doctor with extensive international clinical experience. Originally from Nigeria, he has worked across multiple European healthcare systems and currently practises in Sweden. This professional path has given him a strong understanding of different medical approaches and the ability to work effectively with patients from diverse cultural and linguistic backgrounds.

Dr Okeke focuses on general internal medicine and adult primary care, combining clinical accuracy with careful attention to lifestyle, personal context, and everyday health concerns. His consultations are particularly well suited for people who seek medical advice online, live abroad, or need clear guidance without unnecessary complexity.

He provides online consultations covering symptom assessment, prevention, and long-term management of chronic conditions, helping patients understand what is happening and decide on appropriate next steps.

Common reasons for consultation:

  • General internal medicine concerns and initial health assessment.
  • Acute symptoms such as fever, cough, infections, pain, or weakness.
  • Chronic conditions and treatment adjustment.
  • Blood pressure issues, fatigue, metabolic concerns.
  • Preventive consultations and routine check-ups.
  • Interpretation of laboratory results and medical reports.
  • Medical advice for patients receiving care online.

Dr Okeke is known for his clear communication, calm approach, and cultural awareness. He listens carefully, explains medical decisions in a structured way, and supports patients in making informed choices about their health.

Online consultations with Dr Chikeluo Okeke offer reliable internal medicine care without geographic limitations, focused on medical relevance, clarity, and patient comfort.

Get CEQUA 0.9 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for CEQUA 0.9 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS?

CEQUA 0.9 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in CEQUA 0.9 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS?

The active ingredient in CEQUA 0.9 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS is ciclosporin. This information helps identify medicines with the same composition but different brand names.

Who manufactures CEQUA 0.9 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS?

CEQUA 0.9 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS is manufactured by Sun Pharmaceutical Industries (Europe) B.V.. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of CEQUA 0.9 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether CEQUA 0.9 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy CEQUA 0.9 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy CEQUA 0.9 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to CEQUA 0.9 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS?

Other medicines with the same active substance (ciclosporin) include IKERVIS 1 mg/ml eye drops in emulsion, VERKAZIA 1 mg/ml EMULSION EYE DROPS, ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media